em. prof. dr. Geert Leroux-Roels
- Work address
-
C. Heymanslaan 10, ingang 22 - verdieping 2
9000 Gent - Geert.LerouxRoels@UGent.be
- ORCID iD
-
0000-0001-5968-2542
Show
Sort by
-
- Journal Article
- open access
Characterization of the cell-mediated immune response to Takeda’s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting
-
- Journal Article
- A1
- open access
Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine
-
- Journal Article
- A1
- open access
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6 (R) cell-line : a phase 1 randomized controlled trial in adults
-
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers : a phase 1 trial
-
- Journal Article
- A1
- open access
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults : two clinical trials
-
- Journal Article
- A1
- open access
A role for B cells to transmit hepatitis C virus infection
-
- Journal Article
- A1
- open access
Detection of H1 swine influenza a virus antibodies in human serum samples by age group
-
- Journal Article
- A1
- open access
Adjuvant-associated peripheral blood mRNA profiles and kinetics induced by the adjuvanted recombinant protein candidate tuberculosis vaccine M72/AS01 in Bacillus Calmette–Guérin-vaccinated adults
-
- Journal Article
- A1
- open access
Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins
-
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1